Liquid Biopsy Clinical Trials

10 recruiting

Liquid Biopsy Trials at a Glance

11 actively recruiting trials for liquid biopsy are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Tianjin, Rome, and Manchester. Lead sponsors running liquid biopsy studies include Tianjin Medical University Second Hospital, Regina Elena Cancer Institute, and University Hospital, Montpellier.

Browse liquid biopsy trials by phase

Treatments under study

About Liquid Biopsy Clinical Trials

Looking for clinical trials for Liquid Biopsy? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Liquid Biopsy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Liquid Biopsy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

Bladder CancerImmunotherapyLiquid Biopsy
Tianjin Medical University Second Hospital53 enrolled1 locationNCT07475403
Recruiting
Not Applicable

Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer

Bladder CancerLiquid BiopsyCystoscopy
Tianjin Medical University Second Hospital360 enrolled2 locationsNCT07180212
Recruiting

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

Breast Cancer, Liquid Biopsy, Early Detection
Syantra Inc.2,000 enrolled4 locationsNCT07219277
Recruiting

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

Bladder CancerLiquid Biopsy
Tianjin Medical University Second Hospital60 enrolled2 locationsNCT07130578
Recruiting

Using Liquid Biopsy Testing to Identify, Monitor, Predict Recurrence in Urothelial Carcinoma

Urothelial Carcinoma (UC)Bladder (Urothelial, Transitional Cell) CancerLiquid Biopsy
Tianjin Medical University Second Hospital300 enrolled1 locationNCT07441499
Recruiting
Not Applicable

Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

Bladder CancerLiquid BiopsyRepeat Transurethral Resection of Bladder Tumor
Tianjin Medical University Second Hospital196 enrolled2 locationsNCT07187635
Recruiting

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

Pancreatic Ductal AdenocarcinomaMinimal Residual DiseasectDNA+2 more
University Hospital, Montpellier37 enrolled1 locationNCT06287749
Recruiting
Not Applicable

Liver Cancer and Immunotherapy in the Liquid Biopsy Era

Hepatocellular CarcinomaImmune Checkpoint InhibitorLiquid Biopsy+2 more
University Hospital, Montpellier60 enrolled1 locationNCT05810402
Recruiting

Versatile Ampification Single-Molecule Detection in Liquid Biopsy

Melanoma Stage IVMelanoma (Skin)Melanoma Stage III+1 more
Regina Elena Cancer Institute20 enrolled1 locationNCT05940311
Recruiting

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

Lymph Node MetastasisLiquid BiopsySquamous Cell Carcinoma of the Oropharynx+3 more
Regina Elena Cancer Institute142 enrolled1 locationNCT05918510
Recruiting

The Jinling Cohort

CancerLiquid BiopsyMulti Cancer Early Screening
Nanjing Shihejiyin Technology, Inc.15,000 enrolled2 locationsNCT06011694